top of page
Nevia bio
Nevia site photo.png

The new way for early detection

Nevia; Ne-via
Noun, female, singular
Prophetess, a women who foretells future events

*

Our Services

Who we are

Women • Health • First

At Nevia, we are focused on women's health.

Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.

We believe in empowering women to take control of their health by providing them with the tools they need to live a healthy life. Our team is made up of passionate individuals with diverse backgrounds in healthcare, technology, and business.

Together, we are working towards a future where women's health is a top priority.

Founders

Inbal Zafir Lavia
  • LinkedIn
Shlomit Yehudai Reshef
  • LinkedIn

CEO & Co-founder

Inbal Zafir Lavie, PhD

CSO & Founder

Shlomit Yehudai Reshef, PhD

Roni Michaely
  • LinkedIn

Co-founder

Roni Michaely, PhD

Team

Shiri Blumenfeld Kan
  • LinkedIn
Valeria Miller
  • LinkedIn

Scientific Project Manager and
Regulatory Affairs Specialist

Clinial Operations Manager

Shiri Blumenfeld Kan, PhD, MBA

Valeria Miller, BSc, MBA

Zohar Shnaider
  • LinkedIn

Data Scientist

Zohar Shnaider

Board of Directors

Inbal Zafir Lavie
  • LinkedIn
Shlomit Yehudai Reshef
  • LinkedIn

CEO & Co-founder

Inbal Zafir Lavie, PhD

CSO & Founder

Shlomit Yehudai Reshef, PhD

Anula Jayasuriya
  • LinkedIn

Chair of the board

Anula Jayasuriya

 MD, PhD, MBA

Ophir Shoham

Board member

Ophir Shoham

Dan Shwarzman

Board member

Dan Shwarzman

Clinical Advisory Board

Prof. Rob Coleman
Prof. Brian Slomovitz
Prof. Eitan Friedman

Prof. Rob Coleman

Chief Medical Officer, Vaniam Group, GOG Partners, Special Advisor to the President, GOG Foundation, Board Of Directors

Prof. Brian Slomovitz

Director, Gynicologic Oncology and CoChair, Cancer Research Committee, Mount Sinai Medical Center, Board of Directors and Uterine Cancer Lead, GOG Foundation

Prof. Eitan Friedman

Director and founder of the The Suzanne Levy-Gertner Oncogenetics Unit at the Sheba Medical Center

Prof. Ruth Peretz

Prof. Ruth Perets

Medical Oncologist Rambam Division of Oncology. Head of the Women's Cancers Research Lab at Rambam Health Care Campus. Directs the Phase 1 Clinical Trials in Oncology 

Nevia bio team

Our
Solution

Swab
Biomarkers

Simple vaginal swab

Biomarkers data

Ovarian cancer is also called “the silent killer".

More than 310,000 cases are diagnosed every year worldwide, and 75% of patients are diagnosed at late stages,  resulting in less than 30% survival rates.

Therefore, there is a growing demand for early-diagnosis solutions.

Nevia's platform will save lives of women around the world by enabling early detection.

Data base
Identify patients

Machine learning

Identify patients

Contact

Pipeline

Program

Indication

Development Stage

Biobank

Clinical
POC

FDA
Approval

Nevia-001

Nevia-002

Nevia-003

Ovarian cancer

Endometriosis

To be disclosed

Why Us

Samsung Next

HLTH Diverse founders

Frost and Salivan
Mass Challenge winner
Marker

Israeli femtech innovation leadership award

First Place Pitch Competition

Top 20 most promising companies

Career opportunities

General Application

We are always happy to hear from talented team players

Director of Clinical Affairs

Key leadership position leading the planning and execution of Nevia Bio Clinical Studies activities.

Contact Us
Nevia bio

Thank you for contacting! 

bottom of page